Author:
Scheffer Hester J.,Vroomen Laurien G P H,Nielsen Karin,van Tilborg Aukje A J M,Comans Emile F I,van Kuijk Cornelis,van der Meijs Bram B.,van den Bergh Janneke,van den Tol Petrousjka M P,Meijerink Martijn R.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference39 articles.
1. Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging. 2011;36:635–47.
2. Abdalla EK, Vauthey J-N, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg Oncol. 2004;239:818–25. discussions 825–7.
3. Gleisner A, Choti MA, Assumpcao L, Nathan H, Schulick R, Pawlik T. Recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg. 2014;143:1204–12.
4. De Baere T, Elias D, Dromain C, Gamal El Din M, Kuoch V, Ducreux M, et al. Hepatic Metastases with a Mean Follow-Up of More Than 1 Year. AJR Am J Roentgenol. 2000;175(December):1619–25.
5. Cannon R, Ellis S, Hayes D, Narayanan G, Martin RCG. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2012;107(October):544–9.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献